- Home
- ELTK vs MNOV Comparison
ELTK vs MNOV Comparison
Compare ELTK & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELTK | MNOV |
|---|---|---|
| Founded | 1970 | 2000 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.9M | 76.5M |
| IPO Year | 1997 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ELTK | MNOV |
|---|---|---|
| Price | $9.40 | $1.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 31.4K | ★ 103.8K |
| Earning Date | 11-18-2025 | 11-12-2025 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $49,310,000.00 | $257,917.00 |
| Revenue This Year | $18.60 | N/A |
| Revenue Next Year | $9.04 | N/A |
| P/E Ratio | $54.80 | ★ N/A |
| Revenue Growth | ★ 2.54 | N/A |
| 52 Week Low | $7.65 | $1.13 |
| 52 Week High | $12.19 | $2.24 |
Technical Indicators
Market Signals| Indicator | ELTK | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 54.72 |
| Support Level | $8.85 | $1.48 |
| Resistance Level | $9.80 | $1.60 |
| Average True Range (ATR) | 0.45 | 0.06 |
| MACD | 0.13 | -0.00 |
| Stochastic Oscillator | 73.63 | 57.89 |
Price Performance
Historical ComparisonAbout ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.